Essa Pharma Gross Profit

Essa Pharma (EPIX) currently reports a gross profit of $-16K as of June 2025. That compares with $-95K in the prior-year period — up 82.8% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore Essa Pharma's gross profit history and peer comparisons.

Essa Pharma's gross profit increased from $-95K to $-16K — a 82.8% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Essa Pharma's gross profit of $-16K is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Essa Pharma reported $-16K in gross profit as of June 2025. That compares with $-95K in the prior-year period — up 82.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-16K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for Essa Pharma, and consider following EPIX for alerts when major investors trade the stock.